Human Microbiome Market is valued at USD 210.3 Million in 2018 and expected to reach USD 744.6 Million by 2025 with the CAGR of 19.8% over the forecast period.
The latest report pertaining to Human Microbiome Market provides a detailed analysis regarding market size, revenue estimations and growth rate of the industry. In addition, the report illustrates the major obstacles and newest growth strategies adopted by leading manufacturers who are a part of the competitive landscape of this market.
Key Players-
Global human microbiome market report covers prominent players like Avidbiotics Inc., Avidbiotics Corp., 4D Pharma, Series Therapeutics, Second Genome, Enterome, MicroBiome Therapeutics, LLC, Rebiotix Inc., Yakult Honsha Co., Ltd., Osel Inc., Vedanta Biosciences, Inc., Metabiomics Corporate, Synthetic Biologics, Inc., DuPont, BiomX Ltd., and others.
North America is Expected to Dominate the Global Market–
North America is expected to dominate the global human microbiome market and held major market share due to the growing funding and research and development activities by companies and research institutes in this region. The presence of a large number of players who are adopting various initiatives such as investment in research and development for the development of the new therapeutic area for microbiome to prevent health issues such as irritable bowel syndrome, immune diseases, etc. is further contributing to the market in this region.
Key Benefits for Market Report–
- Global Human Microbiome Market report covers in depth historical and forecast analysis.
- Global Human Microbiome Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global Human Microbiome Market report helps to identify opportunities in market place.
- Global Human Microbiome Market report covers extensive analysis of emerging trends and competitive landscape.
Market Segmentation: –
By Product Type:
- Probiotics
- Prebiotics
- Symbiotics
- Other Products
By Application:
- Therapeutics
- Diagnostics
By Diseases:
- Obesity
- Diabetes
- Autoimmune Disorder
- Cancer
- Gastrointestinal Disorders
- Central Nervous System Disorders
- Other Diseases
By Regional & Country Analysis:
- North America
- US.
- Mexico
- Canada
- Europe
- UK
- France
- Germany
- Italy
- Asia Pacific
- China
- Japan
- India
- Southeast Asia
- Latin America
- Brazil
- The Middle East and Africa
- GCC
- Africa
- Rest of Middle East and Africa
